As of Aug 28
| +0.15 / +2.76%|
The 1 analysts offering 12-month price forecasts for Sinovac Biotech Ltd have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a +34.41% increase from the last price of 5.58.
The current consensus among 1 polled investment analysts is to Buy stock in Sinovac Biotech Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.